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The ATR and ATM checkpoint kinases preserve the integrity of replicating chromosomes by
preventing the reversal of stalled and terminal replication forks. Hu et al. now show that the ATR
pathway targets the Dna2 nuclease to process stalled forks and counteract fork reversal.Eukaryotic chromosome replication is
tightly controlled to ensure the accurate
duplication of genetic information and
preservation of genomic integrity. During
DNA synthesis, replication fork progres-
sion is impeded by DNA topological strain
that is magnified in the proximity of tran-
scribed regions or at replication termina-
tion (Bermejo et al., 2012). In response
to replication stress induced by DNA
damaging agents, replication forks stall
in front of DNA lesions and become
vulnerable. The positive torsional strain
generated when forks pause may con-
tribute to the unwinding of nascent
strands from the template, facilitating
their annealing and generating four-
branched DNA structures known as re-
versed forks or ‘‘chicken foot’’ structures.
In normal cells fork reversal is a very rare
event. Reversed forks can be dangerous
because they resemble Holliday junctions
and may trigger unscheduled homolo-
gous recombination events contributing
to genomic instability (Branzei and Foiani,
2010). The ataxia telangiectasia related
(ATR) and ataxia telangiectasia mutated
(ATM) checkpoint kinases control the
stability of replicating chromosomes,
thereby preventing fork reversal at stalled
and terminal forks (Doksani et al., 2009;
Sogo et al., 2002). In budding yeast, theMec1ATR pathway targets the ribonu-
cleotide reductase inhibitor Sml1 and the
Mlp1TPR nucleoporin to respectively facil-
itate DNA polymerase processivity and
simplify the topological context of tran-
scribed chromatin (Bermejo et al., 2012).
These phosphorylation events seem
crucial to prevent fork reversal. In this
issue of Cell, Hu et al. (2012) describe a
new Rad3ATR-mediated mechanism that
prevents fork reversal in fission yeast.
The authors report that in response
to replication stress, Cds1CHK2, a kinase
downstream of Rad3ATR, phosphorylates
the nuclease Dna2 on serine 220. Phos-
phorylated Dna2 remains stably associ-
ated with stalled forks and cleaves the
flap DNA strands arising when the
nascent chains unwind from the template,
thus counteracting the formation of the
reversed branch of the chicken foot struc-
ture. Hence, Dna2 maintains replication
forks in a normal three-branch configura-
tion at the expense of tracts of newly-
synthesized DNA. Accordingly, dna2
mutants, like cds1CHK2mutants, accumu-
late cruciform reversed forks.
The work of Hu et al. highlights the
important new role of Dna2 in maintaining
replication fork integrity. Under unper-
turbed replication conditions, Dna2 asso-
ciates with the flap DNA chains arisingduring ongoing lagging strand synthesis
(Bae et al., 2001). Several nucleases
participate in the processing of Okazaki
fragments at the lagging strand, including
Fen1, Rnase HI, and Exo1. Dna2, how-
ever, seems specialized in removing long
DNA flaps coated by replication protein A
(RPA) (Bae et al., 2001). RPA-single-
stranded DNA (ssDNA) nucleofilaments
promote activation of the DNA damage
checkpoint, and Dna2 at the lagging
strand indirectly counteracts the forma-
tion of checkpoint signals that otherwise
cause an irreversible growth arrest that
is checkpoint-dependent (Budd et al.,
2011). Accordingly, in budding yeast,
Dna2 becomes dispensable for cell
viability, specifically when the checkpoint
is defective (Budd et al., 2011). Dna2
also contributes to the resection of DNA
double-strand breaks, thus generating
ssDNA tails that engage homologous
recombination activities and also promote
checkpoint activation (Symington and
Gautier, 2011 and references therein).
Hence, Dna2, besides being regulated
by the checkpoint machinery, positively
and negatively influences the formation
of checkpoint signals, depending on the
context.
Several important questions arise from
the study by Hu et al. Are the flap DNA49, June 8, 2012 ª2012 Elsevier Inc. 1181
Figure 1. Dna2-Mediated Transitions at Stalled Forks
Models for DNA2-mediated transitions at stalled forks are depicted. Top left: A paused fork is shown in
which lagging strand processing is delayed due to Dna2 phosphorylation. A flap DNA chain arises at an
Okazaki fragment. The slow lagging processing can trigger template switching events. In an alternate
scenario (top right) 50 or 30 flap DNA strands arise likely due to the topological stress accumulated in the
proximity of the fork. In either situation phosphorylated Dna2 could cleave the flap DNA strands, leading to
the formation of stable gapped forks, perhaps with the contribution of other nucleases such as Exo1. In
contrast, pausing could lead to fork reversal and result in genomic instability.chains originating at stalled forks coated
by RPA and do they trigger ATR activa-
tion? Previous observations show that
in hydroxyurea rad53CHK2 treated cells
(Sogo et al., 2002), short ssDNA gaps
accumulate asymmetrically at the fork
branching points. It has been suggested
that these ssDNA gaps might originate
as a result of the uncoupling of leading
and lagging strand synthesis and repre-
sent an early step in signaling a stalled
fork. An alternative hypothesis, based on
the work by Hu et al., is that the first
consequence of fork stalling is the forma-
tion of flap ssDNA chains, which may
promote ATR activation. The asymmetric
gaps at the points of fork branching may
rather result from Dna2-mediated cleav-
age of the strands with the nascent flap
(Figure 1) and only partially contribute to
checkpoint activation.
Another relevant issue is whether at
stalled forks the chains with nascent flaps1182 Cell 149, June 8, 2012 ª2012 Elsevier Inresult from the processing of Okazaki
fragments at the lagging strand or
whether they form stochastically at the
lagging or the leading strand as a result
of topological stress. Hu et al. show that
in vitro Dna2 can efficiently cleave re-
gressed leading or lagging strands. We
note that besides Dna2, Exo1 has also
been implicated in counteracting fork
reversal at stalled forks (Cotta-Ramusino
et al., 2005), and the two nucleases act
at different steps during Okazaki fragment
processing. These observations, together
with the finding that the abnormal replica-
tion structures accumulated in Rad53CHK2
defective cells resemble lagging strands
defects (Sogo et al., 2002) may suggest
that lagging strand synthesis and pro-
cessing are highly regulated by the check-
point kinases to prevent aberrant transi-
tions at stalled forks and that the flap
DNA strands arise preferentially at the
lagging strand. In this scenario, thec.checkpoint-mediated phosphorylation of
Dna2 at stalled forks might have addi-
tional implications. In normal cells experi-
encing replication stress, fork pausing
may trigger transient uncoupling between
leading and lagging strand synthesis to
promote template switching events
behind the fork, which are ideal for
replicating across a damaged template
(Branzei and Foiani, 2010). The first step
of template switching is the annealing
of nascent strands, which might be
facilitated by a slow mode of lagging
replication. Perhaps the checkpoint-
mediated phosphorylation of Dna2 may
slow down lagging strand processing,
thus contributing to the uncoupling of
leading and lagging strand synthesis to
provide a window of opportunity for
template switching.However, aprolonged
arrest of the replication fork would be
dangerous as template switching may
not be productive, and Dna2 would
promote the removal of the flap DNA
chains that would otherwise trigger fork
reversal (Figure 1).
Hu et al. find that the phosphomimetic
dna2-S220Dmutants only partially rescue
the sensitivity of cds1CHK2 mutants to
treatment with hydroxyurea, a replication
inhibitor. This may reflect the complexity
of the ATR-regulated mechanisms that
counteract fork reversal. It remains to
be determined whether other Cds1CHK2
targets (such as Mus81-Eme1 complex,
Rqh1, or Rad60) play any roles in prevent-
ing fork reversal. Moreover, it would be
relevant to address whether Dna2 also
acts at terminal forks to prevent fork
reversal.
In any case, Dna2 plays a key role in
maintaining genome stability and the find-
ings by Hu et al. provide a mechanistic
framework for the recent observations
that human Dna2 enhances cellular toler-
ance to replication stress and that Dna2
levels are clinically relevant to cancer
(Peng et al., 2012).ACKNOWLEDGMENTS
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p53 is a key tumor suppressor protein that has numerous functions. Its primary mode of action has
generally been ascribed to the induction of cell-cycle arrest, apoptosis, or senescence upon stress.
Li et al. challenge this dogma with evidence that all three of these programs are dispensable for
p53’s tumor suppressive role.Over the past 30 years, the p53 tumor
suppressor has been subjected to intense
scrutiny, with a bewildering and ever-
increasing number of functions and activi-
ties attributed to it. A general consensus
has emerged, however, that the key func-
tion of p53 in preventing tumor develop-
ment is the ability to inhibit the outgrowth
of inchoate cancers. An elegant and
simple model built on numerous studies
dictates thatmanyof the stress signals en-
countered by nascent tumor cells (such as
oncogene activation, telomere erosion,
hypoxia, and genotoxic damage) lead to
the activation of p53, which in turn drives
the expression of genes that coordinate
programs of three key responses: cell-
cycle arrest, apoptosis, and senescence
(Vousden and Prives, 2009) (Figure 1).
The cell exposed to oncogenic stress is
therefore prevented from further prolifera-
tion and tumor development avoided.
So the publication of a paper entitled
‘‘Tumor Suppression in the Absence
of p53-Mediated Cell-Cycle Arrest,
Apoptosis, and Senescence’’ will cause
some excitement and possibly a degreeof consternation in the field (Li et al.,
2012). Has all our thinking so far been
misled? If these three activities are not
required for p53 to suppress tumor devel-
opment, then what is? Are the other activ-
ities of p53—that have so far been
thought of rather as support roles—really
the key to cancer prevention? Certainly
this very interesting study will generate
much attention.
p53 is a transcription factor and acts
primarily to regulate gene expression.
Although much of the regulation of p53
activity is determined by the stability of
the p53 protein, a large number of post-
translational modifications on p53 also
function to regulate DNA binding and
engagement with the transcriptional
machinery (Dai and Gu, 2010). In general,
events such as phosphorylation or acety-
lation on individual sites have rather
modest effects on p53 activity, and iden-
tifying key modifications that are critical
for p53 function has proven to be rather
frustrating. Now Li et al. provide evidence
that a p53 protein mutated in three of the
lysines that are subject to acetylation inthe wild-type protein (the 3KR mutant)
fails to induce cell-cycle arrest, apoptosis,
or senescence in mice (supporting results
from the same group showing acetylation
is important for these three p53 functions
in cells)—but yet retains the ability to
protect mice from tumor development.
Maybe this should not be so surprising;
indeed several previous studies have
hinted that not all these responses are
always required (Bieging and Attardi,
2012). Loss of the primary mediators of
p53-induced cell-cycle arrest (p21) or
apoptosis (PUMA) clearly do not to lead
to tumor susceptibility in the same way
as loss of p53. Other p53 mutants that
are defective in apoptosis or cell-cycle
arrest have been shown to retain tumor
suppressor activity (Brady et al., 2011;
Liu et al., 2004), although in these cases
at least one of the ‘‘big three’’ responses
was retained. Intriguingly, the p53-medi-
ated induction of arrest and apoptosis
that is seen in the immediate response
following irradiation was shown to be
irrelevant for suppression of radiation-
induced lymphoma (Christophorou et al.,49, June 8, 2012 ª2012 Elsevier Inc. 1183
